Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Alvaro Urbano-Ispizua"'
Autor:
Siddhartha Ganguly, Andrew Daly, Tracey A. O'Brien, Melhem Solh, Steven Z. Pavletic, Rammurti T. Kamble, Leslie Lehmann, Tao Wang, Takanori Teshima, Amer Beitinjaneh, Miguel Pérez, Mahmoud Aljurf, Mukta Arora, John L. Wagner, Medhat Askar, Marjolein van der Poel, Madan Jagasia, Rabi Hanna, Alvaro Urbano-Ispizua, Ravi Vij, Armin Rashidi, Taiga Nishihori, Catherine J. Lee, A. Samer Al-Homsi, Vijaya Raj Bhatt, Michael T. Hemmer, Roger Strair, Hannah Choe, Joseph Pidala, Jeffery J. Auletta, Hisham Abdel-Azim, Vaibhav Agrawal, Shahinaz M. Gadalla, Stefan O. Ciurea, S Spellman, Margaret L. MacMillan, Rodrigo Martino, Jean-Yves Cahn, Mitchell S. Cairo, Basem M. William, Rizwan Romee, Jean A. Yared, Navneet S. Majhail, Annie Im, Usama Gergis, Mohamed A. Kharfan-Dabaja, Richard F. Olsson, Sagar S. Patel, Baldeep Wirk, Peiman Hematti, Michael Byrne, Asad Bashey, Hemant S. Murthy, Betty K. Hamilton, Muna Qayed, Pooja Khandelwal, Robert Peter Gale, Saurabh Chhabra, Gerhard C. Hildebrandt, Jan Cerny, Sachiko Seo, Roger H. Herzig, Nosha Farhadfar, Deepesh Lad, Hélène Schoemans, Akshay Sharma, Tim Prestidge, Lazaros J. Lekakis, Daniel J. Weisdorf, Paul Castillo, Miguel-Angel Perales
Publikováno v:
Biol Blood Marrow Transplant
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVH
Autor:
Montserrat Rovira, Laura Rosiñol, Nuria Martínez-Cibrian, Alejandra Martínez-Trillos, Francesc Fernández-Avilés, M. A. Marcos, Carolina Garcia-Vidal, Carmen Martínez, Veselka Dimova-Svetoslavova, Beatriz Martín-Antonio, Alvaro Urbano-Ispizua, Gonzalo Gutiérrez-García, Neus Villamor, María Suárez-Lledó
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:2088-2093
This study examined the impact of prednisone (PDN) on cytomegalovirus (CMV) infection after allogeneic stem cell transplantation (allo-SCT) according to donor and recipient CMV serostatus. Seventy-five patients underwent allo-SCT from June 2010 to Ju
Autor:
Alexandra Pedraza, Pedro Marín, Montserrat Rovira, Gonzalo Gutiérrez-García, Joan Cid, Ana Sofía Almeida Jorge, Luis Gerardo Rodríguez-Lobato, Laura Rosiñol, Alvaro Urbano-Ispizua, Cristina Gallego, Carmen Martinez, Pedro Puerta-Alcalde, Francesc Fernández-Avilés, Carolina Garcia-Vidal, María Suárez-Lledó, Adelina Hernando, Alexandra Martínez-Roca, Susana Segura, Celia Cardozo, David Moreno, Miquel Lozano
Publikováno v:
Leukemialymphoma. 61(7)
Despite the use of fluoroquinolone (FQ) prophylaxis, neutropenic fever (NF) is the most frequent cause of hospital readmission in ambulatory care programs for patients treated with autologous stem cell transplantation (ASCT). We analyzed the impact o
Autor:
Peter Bader, Micha Srour, Nicolaus Kröger, John Murray, Halvard Bonig, Selim Corbacioglu, Stephen P. Robinson, Hermann Einsele, Michael Hudecek, Patrick Hayden, Rafael F. Duarte, Alvaro Urbano-Ispizua, Ulrike Köhl, John A. Snowden, Grzegorz W. Basak, Christian Chabannon, Jürgen Kuball, Mohamad Mohty, Jan Styczyński, Arnon Nagler, Ibrahim Yakoub-Agha, Riccardo Saccardi, Stephan Mielke, Marie José Kersten, Fabio Ciceri, Fermín Sánchez-Guijo
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2020, 105 (2), pp.297-316. ⟨10.3324/haematol.2019.229781⟩
Haematologica, 2020, 105 (2), pp.297-316. ⟨10.3324/haematol.2019.229781⟩
Haematologica, Ferrata Storti Foundation, 2020, 105 (2), pp.297-316. ⟨10.3324/haematol.2019.229781⟩
Haematologica, 2020, 105 (2), pp.297-316. ⟨10.3324/haematol.2019.229781⟩
International audience; Chimeric antigen receptor (CAR) T cells are a novel class of anti-cancer therapy in which autologous or allogeneic T cells are engineered to express a CAR targeting a membrane antigen. In Europe, tisagenlecleucel (Kymriah™)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b991d223e530e2bfbca91ba7a666469
http://publikationen.ub.uni-frankfurt.de/files/53554/container.zip
http://publikationen.ub.uni-frankfurt.de/files/53554/container.zip
Autor:
Gonzalo Gutiérrez-García, Gloria Carbassé, Carlos Castillo, Miquel Lozano, María Suárez-Lledó, Alvaro Urbano-Ispizua, Francesc Fernández-Avilés, Nuria Monfort, Laura Rosiñol, Pedro Marín, Joan Cid, Carmen Martínez, Dolores Herrera, Montserrat Rovira
Publikováno v:
TransfusionREFERENCES. 60(4)
BACKGROUND Plerixafor should be administered 6 to 11 hours before starting leukocytapheresis. However, we have been using plerixafor followed by leukocytapheresis according to different time schedules since 2007. Our objective was to compare the CD34
Autor:
Alvaro Urbano-Ispizua, Laura Rosiñol, Montserrat Rovira, Ana Sofía Almeida Jorge, María Suárez-Lledó, Carmen Martinez, Gonzalo Gutierrez, Arturo Pereira, Francesc Fernández-Avilés, Noemí Llobet, Teresa Solano
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:1196-1202
The optimal prophylaxis regimen for graft-versus-host disease (GVHD) in the setting of mismatched unrelated donor (MMUD) allogeneic hematopoietic stem cell transplantation (alloHSCT) is not defined. The use of high-dose post-transplant cyclophosphami
Autor:
Muna Qayed, Mahmoud Aljurf, Leo F. Verdonck, Navneet S. Majhail, Mitchell S. Cairo, Robert Peter Gale, Mohamed A. Kharfan-Dabaja, Michael T. Hemmer, Corey Cutler, Olle Ringdén, Alvaro Urbano-Ispizua, Stephen R. Spellman, Alison W. Loren, Hideki Nakasone, Rammurti T. Kamble, Shatha Farhan, Takanori Teshima, Kirk R. Schultz, Usama Gergis, Daniel R. Couriel, Betty K. Hamilton, Harry C. Schouten, Amin M. Alousi, Melhem Solh, Joseph Pidala, David I. Marks, Margaret L. MacMillan, Gregory A. Hale, Anita J. Kumar, Shahrukh K. Hashmi, Yoshihiro Inamoto, Mukta Arora, Soyoung Kim, Jean-Yves Cahn, Maxim Norkin
Publikováno v:
Blood Advances. 2:1022-1031
Optimal donor selection is critical for successful allogeneic hematopoietic cell transplantation (HCT). Donor sex and parity are well-established risk factors for graft-versus-host disease (GVHD), with male donors typically associated with lower rate
Autor:
Andrew St. Martin, Vanderson Rocha, Rizwan Romee, Monzr M. Al Malki, Mei-Jie Zhang, Ran Reshef, Miguel-Angel Perales, Shannon R. McCurdy, Melhem Solh, Maxim Norkin, Ephraim J. Fuchs, Asad Bashey, Mehdi Hamadani, Alvaro Urbano-Ispizua, Daniel A. Keesler, Sameh Gaballa, Edmund K. Waller, Mary Eapen
Publikováno v:
Blood Advances. 2:299-307
We studied the association between non-HLA donor characteristics (age, sex, donor-recipient relationship, blood group [ABO] match, and cytomegalovirus [CMV] serostatus) and transplant outcomes after T-cell-replete HLA-haploidentical transplantation u
Autor:
Alvaro Urbano-Ispizua, Petra Muus, Amanda Wilson, Antonio Almeida, Russell E. Ware, Hubert Schrezenmeier
Publikováno v:
Haematologica, 102, e76-e79
Haematologica, 102, 3, pp. e76-e79
Haematologica, 102, 3, pp. e76-e79
Studies of children with paroxysmal nocturnal hemoglobinuria (PNH) are scarce and include limited numbers of patients. We compared demographic and clinical characteristics of children and adults in the International PNH Registry. Our data show that,
Autor:
Anita Hill, Robert A. Brodsky, David J. Araten, Alvaro Urbano-Ispizua, Alexander Röth, Austin G. Kulasekararaj, Jeff Szer, Igor Lisukov, Petra Muus, Hubert Schrezenmeier, Amanda Wilson, Jong Wook Lee, Peter Hillmen, Gérard Socié
Publikováno v:
Internal Medicine Journal. 46:1044-1053
BACKGROUND: Paroxysmal nocturnal haemoglobinuria (PNH) is a rare disease. Although much progress has been made in the understanding of the pathophysiology of the disease, far less is known with respect to the clinical outcomes of patients with PNH. F